This is not the most recent version of the article. View current version (7 OCT 2009)

Intervention Protocol

Abatacept for rheumatoid arthritis

  1. Lara Maxwell1,*,
  2. Jasvinder A Singh2

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 13 MAY 2008

DOI: 10.1002/14651858.CD007277


How to Cite

Maxwell L, Singh JA. Abatacept for rheumatoid arthritis (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD007277. DOI: 10.1002/14651858.CD007277.

Author Information

  1. 1

    University of Ottawa, Institute of Population Health, Ottawa, Ontario, Canada

  2. 2

    Minneapolis VA Medical Center, Medicine, Minneapolis, MN, USA

*Lara Maxwell, Institute of Population Health, University of Ottawa, 1 Stewart Street, Ottawa, Ontario, K1N 6N5, Canada. cmsg@uottawa.ca.

Publication History

  1. Publication Status: Unchanged
  2. Published Online: 16 JUL 2008

SEARCH

This is not the most recent version of the article. View current version (07 OCT 2009)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the efficacy and safety of abatacept in reducing disease activity, pain, and improving function in people with rheumatoid arthritis.